¹Tashkent Medical Pediatric Institute; ²Tashkent Medical Academy, Tashkent, Uzbekistan
*Corresponding author: Prof. Yokudhon N. Madjidova, MD, PhD. Head of Department of Neurology, Pediatric Neurology and Medical Genetics of Tashkent Medical Pediatric Institute. Tashkent, Uzbekistan. E-mail: email@example.com
Published: September 24, 2013
Chronic cerebral ischemia (CCI), as a manifestation of age-related pathology shows strong parameters of the morbidity rate among the elderly. Cognitive impairments are one of main expressions of this pathology. The aim of this study was to evaluate the neurophysiological parameters of the cognitive impairments in patients with various stages of discirculatory encephalopathy (DE) in the comparative aspect. The cognitive functions were studied in 60 patients (main group) possessing various degrees of CCI (stages I-III DE) on a comparative basis. Among them, 20 patients had stage I DE (Group 1), 22 patients had stage II DE (Grope 2), and 18 patients had stage III DE (Group 3). The control group included 15 volunteers of comparable age without any manifestations of CCI. The mean age was 62.4±12.4 years. The etiological factors of DE in our observations were arterial hypertension and atherosclerosis of the cerebral vessels, without occlusion of the major artery of head. Based on the neuropsychological tests in 49 patients (81.6%) of the main group, we found cognitive impairments in various degrees of severity. Normal age-related memory loss was observed in 14.9% while mild cognitive impairment (MCI) was seen in 66.7% of the cases. Among the types of MCI, the disregulatory type was observed in 51.6% of patients with stage II-III DE, and the combined type was observed in 45.4% of patients with stage III DE. The EEG-pattern in patients with DE has some peculiarities that are expressed in the predominance of rhythmical slow wave activity and the reduction in the coherence of alpha rhythmic activity that results in a consequent disturbance of the integrated brain activity. Changes in cognitive evoked potentials (CEP P300) were expressed in the shortening of P300 peak latency and an increase in P300 peak amplitude and consequently, a reduction the latency/amplitude ratio in patients having MCI associated with DE.
- Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 2004; 256:183– 194.
- Damulin IV. Vascular demention. Zh Nevrol Psikhiatr Im SS Korsakova 1999; 4:4-11. [Article in Russian].
- Zakharov VV, Yakhno NN. Syndrome of moderate cognitive disorders in the elderly age: diagnostics and treatment. Rus Med J 2004; 10:573-6. [Article in Russian].
- Akhno NN. The urgent questions of the neuropediatrics. In: Advantages in the neurogeriatrics. М 1995; 9-27. [Article in Russian].
- Bennett DA. Mild cognitive impairment. Clin Geriatr Med 2004; 20(1):15-25.
- Budson AE, Price BH. Memory dysfunction. N Engl J Med 2005; 352(7):692-9.
- Levin OS, Smolentseva IG, Ceredsodnom B. Effect of dofaminergic therapy on the neuropsychological function in patients with Parkinson disease. Nevrol J 2004; 3:31-7. [Article in Russian].
- Scoromets AA. Neuromediators at aging of the brain: key for understanding of the disorders of memory and attention. М.: 2005; 16. [Article in Russian].
- Backman L, Ginovart N, Dixon RA, Wahlin TB, Wahlin A, Halldin C, et al. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am J Psychiat 2000; 157(4):635-7.
- Allard P, Englund E, Marcusson J. Caudate nucleus dopamine D2 receptors in vascular dementia. Dement Geriatr Cogn Disord 2002; 14(1):22-5.
- Comijs HC, Dik MG, Deeg DJ, Jonker C. The course of cognitive decline in older persons: results from the Longitudinal Aging Study Amsterdam. Dement Geriatr Cogn Disord 2004; 17(3):136-42.
- Court JA, Perry EK, Kalaria RN. Neurotransmitter changes in vascular dementia. Cerebrovascular disease, cognitive impairment and dementia. Ed. J.O'Brien. London: Martin Dunitz 2004; 133-152.
- O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol 2003; 2(2):89-98.
- DiCarlo A, Baldereschi M, Amaducci L, Maggi S, Grigoletto F, Scarlato G, et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Geriatr Soc 2000; 48(7):775-82.
- Ganguli M, Dodge HH, Shen C, DeKosky ST. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 2004; 63(1):115-21.
The fully formatted PDF version is available.
Int J Biomed. 2013; 3(3):188-191. © 2013 International Medical Research and Development Corporation. All rights reserved.